Pham PT, Pham PC, Donovitch GM: Cardiovascular disease posttransplant. Semin Nephrol. 2007, 27 (4): 430-44. 10.1016/j.semnephrol.2007.03.005.
Article
CAS
PubMed
Google Scholar
Rabin KR, Kamari Y, Avni I, Grossman E, Sharabi Y: Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther. 2005, 3 (3): 465-471. 10.1586/14779072.3.3.465.
Article
CAS
PubMed
Google Scholar
Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006, 29 (6): 1357-1362. 10.2337/dc05-1801.
Article
CAS
PubMed
Google Scholar
Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB: Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006, 8 (3): 264-280. 10.1111/j.1463-1326.2005.00510.x.
Article
CAS
PubMed
Google Scholar
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000, 20 (6): 1595-1599.
Article
CAS
PubMed
Google Scholar
Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi N, Ohashi K, Kihara S, Funahashi T, Rakugi H, Ogihara T: Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005, 45 (6): 1094-1100. 10.1161/01.HYP.0000169444.05588.4c.
Article
CAS
PubMed
Google Scholar
Dzieliñska Z, Januszewicz A, Wiecek A, Demkow M, Makowiecka-Cieśla M, Prejbisz A, Kadziela J, Mielniczuk R, Florczak E, Janas J, Januszewicz M, Ruzyłło W: Decreased plasma concentration of a novel anti-inflammatory protein adiponectin in hypertensive men with coronary artery disease. Thromb Res. 2003, 110 (5-6): 365-369. 10.1016/j.thromres.2003.08.004.
Article
PubMed
Google Scholar
Zoccali C, Mallamaci F, Panuccio V, Tripepi G, Cutrupi S, Parlongo S, Catalano F, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney Int Suppl. 2003, S98-102. 10.1046/j.1523-1755.63.s84.49.x. 84
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002, 13 (1): 134-141.
CAS
PubMed
Google Scholar
Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D, MMKD Study Group: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol. 2005, 16 (4): 1091-1098. 10.1681/ASN.2004090742.
Article
CAS
PubMed
Google Scholar
Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, Kawano Y, Funahashi T, Ogihara T: Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol. 2006, 98 (12): 1603-1608. 10.1016/j.amjcard.2006.07.039.
Article
CAS
PubMed
Google Scholar
Bayes B, Lauzurica R, Granada ML, Serra A, Bonet J, Fontsere N, Salinas I, Romero R: Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. Transplantation. 2004, 78 (1): 26-30. 10.1097/01.TP.0000132561.48217.B1.
Article
CAS
PubMed
Google Scholar
Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. 1999, Geneva, World Health Organization
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106 (25): 3143-3421.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998, 6 (Suppl 2): 51S-209S.
Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17 (9): 2599-2606. 10.1681/ASN.2006040331.
Article
CAS
PubMed
Google Scholar
Zoccali C, Mallamaci F: Adiponectin and renal disease progression: another epidemiologic conundrum?. Kidney Int. 2007, 71 (12): 1195-1197. 10.1038/sj.ki.5002319.
Article
CAS
PubMed
Google Scholar
Fu Y, Luo N, Klein RL, Garvey WT: Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005, 46: 1369-1379. 10.1194/jlr.M400373-JLR200.
Article
CAS
PubMed
Google Scholar
Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003, 46 (4): 459-469.
CAS
PubMed
Google Scholar
Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB: Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005, 90 (8): 4542-4548. 10.1210/jc.2005-0372.
Article
CAS
PubMed
Google Scholar
Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y: Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003, 107: 671-674. 10.1161/01.CIR.0000055188.83694.B3.
Article
CAS
PubMed
Google Scholar
Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003, 52: 1779-1785. 10.2337/diabetes.52.7.1779.
Article
CAS
PubMed
Google Scholar
Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care. 2003, 26: 1745-1751. 10.2337/diacare.26.6.1745.
Article
CAS
PubMed
Google Scholar
Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000, 102: 1296-1301.
Article
CAS
PubMed
Google Scholar
Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, Kihara S, Walsh K: Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007, 117: 375-386. 10.1172/JCI29709.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arita Y, Kihara S, Ouchi N, et al: Adipocyte-derived plasma protein, adiponectin, acts as a platelet-derived growth-factor-BB-binding protein and regulates growth factor-induced common post-receptor signal in vascular smooth muscle cell. Circulation. 2002, 105: 2893-2898. 10.1161/01.CIR.0000018622.84402.FF.
Article
CAS
PubMed
Google Scholar
Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ: Adiponectin stimulates nitric oxide production in vascular endothelial cells. J Biol Chem. 2003, 278: 45021-45026. 10.1074/jbc.M307878200.
Article
CAS
PubMed
Google Scholar
Kumada M, Kihara S, Ouchi N, et al: Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation. 2004, 109: 2046-2049. 10.1161/01.CIR.0000127953.98131.ED.
Article
CAS
PubMed
Google Scholar
Koh K, Quon M, Han S, et al: Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. Hypertension. 2005, 45: 1088-1093. 10.1161/01.HYP.0000166722.91714.ba.
Article
CAS
PubMed
Google Scholar
Yenicesu M, Yilmaz MI, Caglar K, et al: Blockade of the renin-angiotensin system increases plasma adiponectin concentration in type 2 diabetic patients with proteinuria. Nephron Clin Pract. 2005, 99: 115-121. 10.1159/000083929.
Article
Google Scholar
Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM: The effect of thiazolidinedione on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002, 51: 2968-2974. 10.2337/diabetes.51.10.2968.
Article
CAS
PubMed
Google Scholar